Agilent expands life sciences business with two strategic acquisitions Agilent Technology Inc.
Agilent expands life sciences business with two strategic acquisitions Agilent Technology Inc. today announced it is expanding its existence sciences business with two strategic acquisitions sulbutiamine.review . Halo Genomics, a company of innovative technology for the quickly growing next-era DNA sequencing market, has now joined Agilent. In addition, Agilent has signed a definitive acquisition contract with BioSystem Development, a company that creates and manufactures answers to meet the analytical needs of the entire life sciences industry. Both businesses are privately held. Financial details were not disclosed.
Watson enhances this capacity and provides a standardized bioanalytical workflow which allows for efficient and compliant sample managing, data processing, and reporting. It also permits customization so we can effectively meet our client’s needs. We want to have the ability to offer accurate, compliant data in a customer specified format as quickly as possible, stated Brian Lilley Sr. Director of GLP Bioanalysis. Information technology is an essential component in our dedication to lead the industry by creating Better Data Faster said Jim Jersey, CEO and President at Agilux, Watson can be a central element of that IT infrastructure. .. Agilux implements Thermo Watson LIMS for bioanalytical services Agilux Laboratories, a provider of pharmaceutical and biotech services, today announced that it has completed the validation and execution of the Thermo Watson Laboratory Details Management Program for the company’s bioanalytical providers.